HomeCompaniesProfile

Quit Genius

The world's first digital clinic for substance use management 


Company Size

51 - 250 employees

Year Founded

2017


About Quit Genius

Pelago, formerly Quit Genius, is the world’s leading virtual clinic for substance use management. We are transforming substance use support—from prevention to treatment—delivering education, management skills, and opportunities for positive change to members struggling with substance use, most commonly tobacco, alcohol, or opioids. Our solution gives employers the means to offer on-demand, personalized support to workers seeking to live healthier lives. Pelago’s cognitive behavioral therapy (CBT) and medication-assisted treatment (MAT) programs deliver convenient, accessible, and effective support that seamlessly integrates with health plans, pharmacy benefit managers, and wellness platforms. To date, Pelago has helped more than 750,000 members manage their substance use and improve their lives.

Founders & Key People

Yusuf Sherwani

Yusuf Sherwani

Founder/CEO, Quit Genius

Sarim Siddiqui

Sarim Siddiqui

Co-founder of Quit Genius

Maroof Ahmed

Maroof Ahmed

Co-founder of Quit Genius

Share This Profile

More Companies

DailyDoctor

Daily telehealth care for people with COPD, CHF, hypertension, and…

NFTScoring

The NFT exchange for traders

Orchata

Groceries delivered in 20 min in Latinamerica

Skypher

AI agent for Compliance Questionnaires Automation

Giveffect

Fundraising, Volunteer and Donor Management SaaS for nonprofits.

Dropbase

AI app builder for internal tools. Build back-office software faster…

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

© Copyright 2025 BEAMSTART. All Rights Reserved.